2024
DOI: 10.62347/mkiv1986
|View full text |Cite
|
Sign up to set email alerts
|

Galectin inhibitors and nanoparticles as a novel therapeutic strategy for glioblastoma multiforme

Willie Elliott Jr

Abstract: Over the past two decades, the gold standard of glioblastoma multiforme (GBM) treatment is unchanged and adjunctive therapy has offered little to prolong both quality and quantity of life. To improve pharmacotherapy for GBM, galectins are being studied provided their positive correlation with the malignancy and disease severity. Despite the use of galectin inhibitors and literature displaying the ability of the lectin proteins to decrease tumor burden and decrease mortality within various malignancies, galecti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 161 publications
0
0
0
Order By: Relevance